Carrier Cell-based Delivery of an Oncolytic Virus Circumvents Antiviral Immunity

This publication has 37 references indexed in Scilit:

• The role of ICP0-Null HSV-1 and interferon signaling defects in the effective treatment of breast adenocarcinoma
  Molecular Therapy, 2005
• Tumor cells as cellular vehicles to deliver gene therapies to metastatic tumors
  Cancer Gene Therapy, 2005
• Carrier cell‐mediated delivery of oncolytic parvoviruses for targeting metastases
  International Journal of Cancer, 2004
• A Hemodynamic Response to Intravenous Adenovirus Vector Particles Is Caused by Systemic Kupffer Cell-Mediated Activation of Endothelial Cells
  Human Gene Therapy, 2003
• Development of Recombinant Vesicular Stomatitis Viruses That Exploit Defects in Host Defense To Augment Specific Oncolytic Activity
  Journal of Virology, 2003
• Pre-Existent Adenovirus Antibody Inhibits Systemic Toxicity and Antitumor Activity of CN706 in the Nude Mouse LNCaP Xenograft Model: Implications and Proposals for Human Therapy
  Human Gene Therapy, 2000
• Brief Report: Liver Bypass Significantly Increases the Transduction Efficiency of Recombinant Adenoviral Vectors in the Lung, Intestine, and Kidney
  Human Gene Therapy, 2000
• Poly-L-lysine improves gene transfer with adenovirus formulated in PLGA microspheres
  Gene Therapy, 1999
• In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
  Science, 1996
• Effective anti‐metastatic melanoma vaccination with tumor cells transfected with MHC genes and/or infected with newcastle disease virus (NDV)
  International Journal of Cancer, 1994